More Evidence for the Positive Effect of Statins and Metformin in High-Risk Prostate Cancer.
A total of 22,110 high-risk prostate cancer patients were evaluated of which 1,365 died of prostate cancer. The study authors concluded that the use of a statin medication in combination with metformin was associated with a 43% reduction in prostate cancer mortality. The benefit was present in all men but was present to a larger degree in men with obesity.
The preceding abstract was presented at the 2015 meeting of the American Society of Clinical Oncology (ASCO) by Dr. Grace L. Lu-Yao of the University of Medicine and Dentistry of New Jersey.
This entry was posted in 2015
, General Patient Information
. Bookmark the permalink